Skip to the page

Data / Form D filings / CraniUS LLC

CraniUS LLC: Form D filings

CraniUS LLC, a biotechnology company in Baltimore, MD, filed 5 Form D notices with the SEC between 2021 and 2026. The latest, on March 6, 2026, reports $19 million sold of a $20 million offering to 49 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1700 Union Avenue, Ste A-1, Baltimore, MD, 21211
Phone
(410) 404-9151
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Maryland
Year incorporated
2021
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1878219

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 6, 2026New notice$20,000,000$19,000,000$1,000,00049Feb 13, 2026sec.gov
May 25, 2022Amendment$20,000,000$19,420,000$580,00021Aug 19, 2021sec.gov
Dec 9, 2021Amendment$20,000,000$5,350,000$14,650,0007Aug 19, 2021sec.gov
Sep 14, 2021Amendment$50,000,000$500,000$49,500,0001Aug 19, 2021sec.gov
Aug 20, 2021New notice$50,000,000$500,000$49,500,0001Aug 19, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Chad GordonDirector
Sharon WolfingtonDirector
Steven KlaskoDirector
Brian MoranDirector
Elliot StoneDirector
Joshua ScheinkerDirector
Brett FriedmanDirector
Oray Boston, Jr.Director
Michael MaglinExecutive Officer

Other biotechnology companies in Maryland that filed recently

Every Form D from the week of Mar 2, 2026 · All recent filings in Maryland · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what CraniUS LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.